3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Non-small Cell Lung Cancer Metastatic
1
Interventions
pembrolizumab
11
Nivolumab
6
fludarabine phosphate
5
fludarabine
5
Paclitaxel
5
Cisplatin
5
Cetuximab
5
Carboplatin
5
atezolizumab
4
Pemetrexed
4
Docetaxel
4
Cyclophosphamide
4
Bevacizumab
4
durvalumab
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
venetoclax
2
ibrutinib
2
enzalutamide
2
encorafenib
2
binimetinib
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Practice Guidelines as Topic
2
Platinum
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
tusamitamab ravtansine
×
30 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts